- $29.04m
- $150.29m
- CA$191.10m
- 27
- 81
- 30
- 43
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.27 | ||
| Price to Tang. Book | 0.53 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.31 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -124.49% | ||
| Return on Equity | -103.68% | ||
| Operating Margin | -160.96% | ||
Financial Summary
| Year End 31st Jul | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 4.93 | 47.54 | 80.78 | 123.77 | 191.1 | 103.42 | 96.1 | 115.66% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Hexo Corp. is a Canada-based consumer packaged goods cannabis company. The Company is engaged in cultivating, processing, packaging, and distributing cannabis products to serve the cannabis market. The Company serves the Canadian recreational market with a brand portfolio, including HEXO, Redecan, UP Cannabis, Original Stash, 48North, Trail Mix, Bake Sale and Latitude brands, and the medical market under HEXO medical cannabis in Canada and Israel. Its HEXO brand offers a range of flower strains, discreet capsules, and convenient vapes, including the HEXO FLVR lineup of flavor-first vapes, and HEXO Plus high potency flower, exclusive to Quebec. Its brand Namaste is a recreational cannabis brand for mindful consumers.
Directors
- John Bell CHM (74)
- Scott Cooper PRE
- Curtis Solsvig CFO
- Guillaume Joueet CHO
- Roch Vaillancourt GCN
- Valerie Malone OTH
- Rose Gage DRC
- Adam Miron DRC
- Peter Montour DRC
- William Montour DRC
- Vincent Chiara IND
- Emilio Imbriglio IND
- Last Annual
- July 31st, 2022
- Last Interim
- April 30th, 2023
- Incorporated
- October 29th, 2013
- Public Since
- November 17th, 2014
- No. of Employees
- 689
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
NASDAQ Capital Market- Shares in Issue
- 43,996,355
- Address
- 3000 Solandt Rd,, KANATA, K2K 2X2
- Web
- https://www.hexocorp.com/
- Phone
- +1 8444061852
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for HEXO
Q1 2024 Hexo Corp Earnings Release
Similar to HEXO
60 Degrees Pharmaceuticals
NASDAQ Capital Market
Aadi Bioscience
NASDAQ Capital Market
Acasti Pharma
NASDAQ Capital Market
Adamis Pharmaceuticals
NASDAQ Capital Market
Affinia Therapeutics
NASDAQ Capital Market
FAQ
What is the Hexo share price?
As of Today at 19:10 UTC, shares in Hexo are trading at $0.71. This share price information is delayed by 15 minutes.
How has the Hexo share price performed this year?
Shares in Hexo last closed at $0.71 and the price had moved by -75.69% over the past 365 days. In terms of relative price strength the Hexo share price has underperformed the S&P500 Index by -78.13% over the past year.
What are the analyst and broker recommendations for Hexo?
The overall consensus recommendation for Hexo is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Hexo dividend yield?
Hexo does not currently pay a dividend.
Does Hexo pay a dividend?
Hexo does not currently pay a dividend.
When does Hexo next pay dividends?
Hexo does not currently pay a dividend.
How do I buy Hexo shares?
To buy shares in Hexo you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Hexo?
As of the previous close price of $0.71, shares in Hexo had a market capitalisation of $29.04m.
Where are Hexo shares listed?
Here are the trading details for Hexo:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: HEXO
What kind of share is Hexo?
Based on an overall assessment of its quality, value and momentum Hexo is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Hexo share price forecast for 2023?
The analyst consensus target price for shares in Hexo is $0.98. That is 37.84% above the last closing price of $0.71.
Analysts covering Hexo currently have a consensus Earnings Per Share (EPS) forecast of -CA$0.44 for the next financial year.
Find out moreWhat is the trend in the Hexo share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Hexo. Over the past six months, its share price has underperformed the S&P500 Index by -40.45%.
As of the last closing price of $0.71, shares in Hexo were trading -59.06% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Hexo PE Ratio?
The Hexo PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.71.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Hexo?
Hexo's management team is headed by:
- John Bell - CHM
- Scott Cooper - PRE
- Curtis Solsvig - CFO
- Guillaume Joueet - CHO
- Roch Vaillancourt - GCN
- Valerie Malone - OTH
- Rose Gage - DRC
- Adam Miron - DRC
- Peter Montour - DRC
- William Montour - DRC
- Vincent Chiara - IND
- Emilio Imbriglio - IND